GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyclacel Pharmaceuticals Inc (STU:UXI0) » Definitions » Balance Sheet Cash And Cash Equivalents

Cyclacel Pharmaceuticals (STU:UXI0) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 2010. Start your Free Trial

What is Cyclacel Pharmaceuticals Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


Cyclacel Pharmaceuticals Business Description

Industry
Traded in Other Exchanges
Address
Jalan Kerinchi, Level 10, Tower, Avenue 5, No. 8, Kuala Lumpur, SGR, MYS, 592000
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.